Results 221 to 230 of about 20,516 (271)

Targeting transglutaminase 2: pathways to celiac disease therapies. [PDF]

Gastroenterol Rep (Oxf)
Endrizzi A, Grunst P, Rudloff S, De Laffolie J, Zimmer KP, Stricker S.   +5 more
europepmc   +1 more source

The state of shock induced by cystamine and cysteamine.

, 1968
Bacq Zm, Beaumariage Ml, R. Goutier, Van Caneghem P   +3 more
openalex   +1 more source

Zuogui Pill Promotes Neurovascular Regeneration and Corticospinal Tract Remodeling After Ischemic Stroke. [PDF]

Drug Des Devel Ther
Wu D, Yan X, Mei S, Hua H, Fei X, Xu X, Liu Y, Wu M, Zhu J, Li W.   +9 more
europepmc   +1 more source

Clinical Efficacy of Cysteamine Application for Melasma: A Meta-Analysis. [PDF]

J Clin Med
Wu BQ, Wang YJ, Chang CC, Juang TY, Huang YH, Hsu YC.   +5 more
europepmc   +1 more source

Topical AuNPs-Cys-Sm29 gel modulates the course of lesion development in experimental cutaneous leishmaniasis. [PDF]

PLoS Negl Trop Dis
Viana SM, Cardoso L, Borba PB, Carvalho LP, Moreira J, Mambelli F, Oliveira SC, Carvalho EM, de Oliveira CI.   +8 more
europepmc   +1 more source

Editorial: Model organisms in predictive toxicology 2023. [PDF]

Front Pharmacol
Luceri C, Dogan A, León-Buitimea A.
europepmc   +1 more source

2,5-di Boc-cysteamine NADA CDCl3[1]

Wang Qiqi, Cadelis, Melissa, Copp, Brent
openalex   +1 more source

A Case Series With Cysteamine-Isobionicamide Complex: Clues for Skin-Rejuvenating Activity. [PDF]

J Cosmet Dermatol
Clark-Loeser L, Sfriso R, Dirlewanger L, Kasraee B.   +3 more
europepmc   +1 more source

Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter. [PDF]

PLoS One
Tian H, Chu X, Guan Q, Liu J, Liu Y.
europepmc   +1 more source